Broder, C. C. & Wong, K. T. in Neurotropic Viral Infections: Volume 1: Neurotropic RNA Viruses (ed. Reiss, C. S.) (Springer, 2016).

Lamb, R. A. & Parks, G. D. Paramyxoviridae: The Viruses and Their Replication 5th edn (Lippincott, Williams, and Wilkins, 2007).

Amaya, M. & Broder, C. C. Vaccines to emerging viruses: Nipah and Hendra. Annu. Rev. Virol. 7, 447–473 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luby, S. & Gurley, E. in Global Virology I—Identifying and Investigating Viral Diseases (eds Shapshak, P. et al.) (Springer, 2015).

Aguilar, H. C. & Lee, B. Emerging paramyxoviruses: molecular mechanisms and antiviral strategies. Expert Rev. Mol. Med. 13, e6 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Negrete, O. A. et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436, 401 (2005).

Article  CAS  PubMed  Google Scholar 

Zhu, Z. et al. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J. Infect. Dis. 197, 846–853 (2008).

Article  CAS  PubMed  Google Scholar 

Bossart, K. N. et al. A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge. Sci. Transl. Med. 3, 105ra103 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Bossart, K. N. et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog. 5, e1000642 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Geisbert, T. W. et al. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci. Transl. Med. 6, 242ra282 (2014).

Article  Google Scholar 

Mire, C. E. et al. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Sci. Rep. 6, 30916 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Playford, E. G. et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect. Dis. 20, 445–454 (2020).

Article  CAS  PubMed  Google Scholar 

Lamb, R. A., Paterson, R. G. & Jardetzky, T. S. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344, 30–37 (2006).

Article  CAS  PubMed  Google Scholar 

Smith, E. C., Popa, A., Chang, A., Masante, C. & Dutch, R. E. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276, 7217–7227 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avanzato, V. A. et al. A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex. Proc. Natl Acad. Sci. USA 116, 25057 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang, H. V. et al. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nat. Struct. Mol. Biol. 26, 980–987 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang, H. V. et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nat. Struct. Mol. Biol. 28, 426–434 (2021).

Article  CAS  PubMed  Google Scholar 

Byrne, P. O. et al. Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein. Nat. Commun. 14, 1494 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mire, C. E. et al. A cross-reactive humanized monoclonal antibody targeting fusion glycoprotein function protects ferrets against lethal Nipah virus and Hendra virus infection. J. Infect. Dis. 221, S471–S479 (2020).

Article  CAS  PubMed  Google Scholar 

Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671–675 (2021).

Article  PubMed  Google Scholar 

Roessler, A., Riepler, L., Bante, D., von Laer, D. & Kimpel, J. SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons. N. Engl. J. Med. 386, 698–700 (2022).

Article  Google Scholar 

VanBlargan, L. A. et al. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat. Med. 28, 490–495 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borisevich, V. et al. Escape from monoclonal antibody neutralization affects Henipavirus fitness in vitro and in vivo. J. Infect. Dis. 213, 448–455 (2016).

Article  CAS  PubMed  Google Scholar 

Xu, K. et al. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PLoS Pathog. 9, e1003684 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Doyle, M. P. et al. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Rep. 36, 109628 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeitlin, L. et al. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates. Sci. Transl. Med. 16, eadl2055 (2024).

Article  CAS  PubMed  Google Scholar 

Wang, J. et al. A new Hendra virus genotype found in Australian flying foxes. Virol. J. 18, 197 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bradel-Tretheway, B. G. et al. Nipah and Hendra virus glycoproteins induce comparable homologous but distinct heterologous fusion phenotypes. J. Virol. 93, e00577-19 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Valenzuela Nieto, G. et al. Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody. Sci. Rep. 11, 3318 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu, K. et al. Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly. PLoS Pathog. 11, e1005322 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Byrne, Patrick et al. Prefusion stabilization of the Hendra and Langya virus F proteins. J. Virol. 98, e0137223 (2024).

Article  PubMed  Google Scholar 

Isaacs, A. et al. Combinatorial F–G immunogens as Nipah and respiratory syncytial virus vaccine candidates. Viruses 13, 1942 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, Z. et al. An engineered bispecific human monoclonal antibody against SARS-CoV-2. Nat. Immunol. 23, 423–430 (2022).

Article  CAS  PubMed  Google Scholar 

Moirangthem, R. et al. Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity. Mol. Ther. 32, 3712–3728 (2024).

Article